Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9260)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 28, 2017 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Loosen SH, Schueller F, Trautwein C, Roy S, Roderburg C. Role of circulating microRNAs in liver diseases. World J Hepatol 2017; 9(12): 586-594 [PMID: 28515844 DOI: 10.4254/wjh.v9.i12.586] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i12/586.htm |
| Number | Citing Articles |
| 1 |
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
|
| 2 |
Ana Garcia Garcia de Paredes, Nicolo Manicardi, Luis Tellez, Luis Ibañez, Felix Royo, Javier Bermejo, Carolina Blanco, Constantino Fondevila, Val Fernandez Lanza, Laura Garcia‐Bermejo, Juan Manuel Falcon‐Perez, Rafael Bañares, Jordi Gracia‐Sancho, Agustin Albillos. Molecular Profiling of Decompensated Cirrhosis by a Novel MicroRNA Signature. Hepatology Communications 2021; 5(2): 309 doi: 10.1002/hep4.1642
|
| 3 |
Teresa Carbonell, Aldrin V. Gomes. MicroRNAs in the regulation of cellular redox status and its implications in myocardial ischemia-reperfusion injury. Redox Biology 2020; 36: 101607 doi: 10.1016/j.redox.2020.101607
|
| 4 |
Zhiyun Jiang, Junfen Ma, Qian Wang, Fan Wu, Jiedan Ping, Liang Ming. Circulating microRNA expression and their target genes in deep vein thrombosis. Medicine 2017; 96(50): e9330 doi: 10.1097/MD.0000000000009330
|
| 5 |
Gábor Lendvai, Tímea Szekerczés, Idikó Illyés, Réka Dóra, Endre Kontsek, Alíz Gógl, András Kiss, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, Katalin Borka. Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis. Pathology & Oncology Research 2020; 26(1): 3 doi: 10.1007/s12253-018-0491-8
|
| 6 |
Katrin Hoffmann, Alexander Johannes Nagel, Kazukata Tanabe, Juri Fuchs, Karolin Dehlke, Omid Ghamarnejad, Anastasia Lemekhova, Arianeb Mehrabi. Markers of liver regeneration—the role of growth factors and cytokines: a systematic review. BMC Surgery 2020; 20(1) doi: 10.1186/s12893-019-0664-8
|
| 7 |
Terezinha Souza, Panuwat Trairatphisan, Janet Piñero, Laura I. Furlong, Julio Saez-Rodriguez, Jos Kleinjans, Danyel Jennen. Embracing the Dark Side: Computational Approaches to Unveil the Functionality of Genes Lacking Biological Annotation in Drug-Induced Liver Injury. Frontiers in Genetics 2018; 9 doi: 10.3389/fgene.2018.00527
|
| 8 |
Amin Ullah, Irshad Ur Rehman, Katharina Ommer, Nadeem Ahmed, Margarete Odenthal, Xiaojie Yu, Jamshaid Ahmad, Tariq Nadeem, Qurban Ali, Bashir Ahmad. Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3. Genes 2023; 14(5): 1056 doi: 10.3390/genes14051056
|
| 9 |
Tomáš Zárybnický, Petra Matoušková, Bibiána Lancošová, Zdeněk Šubrt, Lenka Skálová, Iva Boušová. Inter-Individual Variability in Acute Toxicity of R-Pulegone and R-Menthofuran in Human Liver Slices and Their Influence on miRNA Expression Changes in Comparison to Acetaminophen. International Journal of Molecular Sciences 2018; 19(6): 1805 doi: 10.3390/ijms19061805
|
| 10 |
Diana Gabriela Iacob, Adelina Rosca, Simona Maria Ruta. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World Journal of Gastroenterology 2020; 26(11): 1113-1127 doi: 10.3748/wjg.v26.i11.1113
|
| 11 |
Francesco Vasuri, Michela Visani, Giorgia Acquaviva, Thomas Brand, Michelangelo Fiorentino, Annalisa Pession, Giovanni Tallini, Antonia D’Errico, Dario de Biase. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(25): 2647-2660 doi: 10.3748/wjg.v24.i25.2647
|
| 12 |
Aline Gottlieb, Ali Canbay. Werden microRNA unsere NAFLD-Marker sein?. Gastro-News 2019; 6(2): 20 doi: 10.1007/s15036-019-0561-0
|
| 13 |
Liwei Guo, Weiyan Li, Liyang Hu, Huanhuan Zhou, Lei Zheng, Lifei Yu, Weifeng Liang. Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis. Oncotarget 2018; 9(4): 5397 doi: 10.18632/oncotarget.23332
|
| 14 |
Ana Garcia Garcia de Paredes, Càndid Villanueva, Carolina Blanco, Joan Genescà, Nicolo Manicardi, Juan Carlos Garcia-Pagan, Jose Luis Calleja, Carlos Aracil, Rosa M. Morillas, Maria Poca, Beatriz Peñas, Salvador Augustin, Juan G. Abraldes, Eldimar Alvarado, Félix Royo, Maria Laura Garcia-Bermejo, Juan Manuel Falcon-Perez, Rafael Bañares, Jaime Bosch, Jordi Gracia-Sancho, Agustin Albillos. Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis. JHEP Reports 2021; 3(6): 100368 doi: 10.1016/j.jhepr.2021.100368
|
| 15 |
O.E. Abaturov, V.L. Babуch. The role of miRNAs in the development of hepatobiliary diseases. CHILD`S HEALTH 2023; 18(1): 65 doi: 10.22141/2224-0551.18.1.2023.1561
|
| 16 |
Chisato Saeki, Juntaro Matsuzaki, Masahiko Kuroda, Koji Fujita, Makiko Ichikawa, Satoko Takizawa, Keiko Takano, Tsunekazu Oikawa, Yasuni Nakanuma, Masayuki Saruta, Takahiro Ochiya, Akihito Tsubota. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis. BMJ Open Gastroenterology 2022; 9(1): e000879 doi: 10.1136/bmjgast-2022-000879
|
| 17 |
Sven H. Loosen, Mirco Castoldi, Markus S. Jördens, Sanchary Roy, Mihael Vucur, Jennis Kandler, Linda Hammerich, Raphael Mohr, Frank Tacke, Tom F. Ulmer, Ulf P. Neumann, Tom Luedde, Christoph Roderburg, Matias A. Avila. Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC. PLOS ONE 2021; 16(3): e0247917 doi: 10.1371/journal.pone.0247917
|
| 18 |
Dong Sun, Jinghui Lu, Chunxiao Hu, Qiangbo Zhang, Xiangdong Wang, Zongli Zhang, Sanyuan Hu. Prognostic role of miR‑760 in hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9546
|
| 19 |
Albert J. Czaja. Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management. Expert Review of Gastroenterology & Hepatology 2018; 12(6): 547 doi: 10.1080/17474124.2018.1453356
|
| 20 |
Jennifer Vogt, Daniel Sheinson, Paula Katavolos, Hiroko Irimagawa, Min Tseng, Kathila R. Alatsis, William R. Proctor, Bernard Mari. Variance component analysis of circulating miR-122 in serum from healthy human volunteers. PLOS ONE 2019; 14(7): e0220406 doi: 10.1371/journal.pone.0220406
|
| 21 |
The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis. Cells 2019; 8(9): 1003 doi: 10.3390/cells8091003
|
| 22 |
Luoluo Xu, Changhua Ji, Xiangling Miao, Junfeng Ge, Fandong Li, Chengwei Xu. Combination of Circulating miR-125a-5p, miR-223-3p and D-dimer as a Novel Biomarker for Deep Vein Thrombosis. The American Journal of the Medical Sciences 2022; 364(5): 601 doi: 10.1016/j.amjms.2022.04.033
|
| 23 |
Teresa Hellberg, Raphael Mohr, Lukas Geisler, Jana Knorr, Alexander Wree, Münevver Demir, Fabian Benz, Joeri Lambrecht, Sven H. Loosen, Frank Tacke, Christoph Roderburg, Henning Jann, Burcin Özdirik, Bernard Mari. Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors. PLOS ONE 2020; 15(12): e0244504 doi: 10.1371/journal.pone.0244504
|
| 24 |
Henk P. Roest, Jan N. M. IJzermans, Luc J. W. van der Laan. Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids. BMC Biotechnology 2021; 21(1) doi: 10.1186/s12896-021-00706-6
|
| 25 |
Ilze Strumfa, Dzeina Mezale, Boriss Strumfs, Andrejs Vanags, Arturs Kalva, Dainis Balodis, Ilze Fridrihsone, Arnis Abolins, Janis Gardovskis. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.76599
|
| 26 |
Jun‑Sheng Ni, Hao Zheng, Zhi‑Ping Huang, Yong‑Gang Hong, Yang‑Liu Ou, Yuan‑Ping Tao, Meng‑Chao Wang, Zhen‑Guang Wang, Yuan Yang, Wei‑Ping Zhou. MicroRNA‑197‑3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9848
|
| 27 |
Pradeep Kumar, Reben Raeman, Daniel M. Chopyk, Tekla Smith, Kiran Verma, Yunshan Liu, Frank A. Anania. Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(10): 3537 doi: 10.1016/j.bbadis.2018.08.012
|
| 28 |
Maryam Gholizadeh, Sylwia Szelag-Pieniek, Mariola Post, Mateusz Kurzawski, Jesus Prieto, Josepmaria Argemi, Marek Drozdzik, Lars Kaderali. Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases. International Journal of Molecular Sciences 2020; 21(19): 7368 doi: 10.3390/ijms21197368
|
| 29 |
Chen Huang, Xian Xing, Xinyu Xiang, Xiaoli Fan, Ruoting Men, Tinghong Ye, Li Yang. MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets. Biomedicine & Pharmacotherapy 2020; 130: 110558 doi: 10.1016/j.biopha.2020.110558
|
| 30 |
Albert J. Czaja. Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitis. Expert Review of Clinical Immunology 2022; 18(6): 591 doi: 10.1080/1744666X.2022.2074839
|
| 31 |
Qiang Wang, Shu Liu, Huan Wang, Lian Liu, Sheng Zhang, Yingzi Ming, Yujun Zhao, Ke Cheng. Silencing long noncoding RNA NEAT1 alleviates acute liver failure via the EZH2-mediated microRNA-139/PUMA axis. Aging 2021; 13(9): 12537 doi: 10.18632/aging.202927
|
| 32 |
Letícia F Ramos, Caio M Silva, Camila C Pansa, Karen C M Moraes. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. Expert Review of Gastroenterology & Hepatology 2021; 15(1): 25 doi: 10.1080/17474124.2020.1820321
|
| 33 |
Catherine Jane Messner, Saskia Schmidt, Dilek Özkul, Carine Gaiser, Luigi Terracciano, Stephan Krähenbühl, Laura Suter-Dick. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation. International Journal of Molecular Sciences 2021; 22(18): 9799 doi: 10.3390/ijms22189799
|
| 34 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 35 |
Susana Sangiao-Alvarellos, Konstantinos Theofilatos, Temo Barwari, Clemens Gutmann, Kaloyan Takov, Bhawana Singh, Paula Juiz-Valiña, Bárbara María Varela-Rodríguez, Elena Outeiriño-Blanco, Elisa Duregotti, Anna Zampetaki, Lukas Lunger, Christoph Ebenbichler, Herbert Tilg, María Jesús García-Brao, Peter Willeit, Enrique Mena, Stefan Kiechl, Fernando Cordido, Manuel Mayr. Metabolic recovery after weight loss surgery is reflected in serum microRNAs. BMJ Open Diabetes Research & Care 2020; 8(2): e001441 doi: 10.1136/bmjdrc-2020-001441
|
| 36 |
Beata Hukowska-Szematowicz, Agata Maciejak-Jastrzębska, Małgorzata Blatkiewicz, Karolina Maciak, Monika Góra, Joanna Janiszewska, Beata Burzyńska. Changes in MicroRNA Expression during Rabbit Hemorrhagic Disease Virus (RHDV) Infection. Viruses 2020; 12(9): 965 doi: 10.3390/v12090965
|
| 37 |
Yuezhu Liu, Hua Zeng, Junmei Xu. Recent Advance on Drug Therapy Related to Myocardial Ischemia Reperfusion Injury. Journal of Biomaterials and Tissue Engineering 2022; 12(2): 299 doi: 10.1166/jbt.2022.2899
|
| 38 |
Ji‐Chang Fan, Fei Zeng, Yi‐Guan Le, Lin Xin. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR‐24‐3p. Journal of Cellular Biochemistry 2018; 119(8): 6391 doi: 10.1002/jcb.26479
|
| 39 |
Albert J. Czaja. Epigenetic Aspects and Prospects in Autoimmune Hepatitis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.921765
|
| 40 |
Lei Li, Chen Xun, Chun-Hong Yu. Role of microRNA-regulated cancer stem cells in recurrent hepatocellular carcinoma. World Journal of Hepatology 2022; 14(12): 1985-1996 doi: 10.4254/wjh.v14.i12.1985
|
| 41 |
Charlotte J. Green, Siôn A. Parry, Pippa J. Gunn, Carlo D.L. Ceresa, Fredrik Rosqvist, Marie-Eve Piché, Leanne Hodson. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models. Hormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2018-0038
|
| 42 |
Luca Dalle Carbonare, Arianna Minoia, Michele Braggio, Jessica Bertacco, Francesca Cristiana Piritore, Sharazed Zouari, Anna Vareschi, Rossella Elia, Ermes Vedovi, Cristina Scumà, Matilde Carlucci, Lekhana Bhandary, Monica Mottes, Maria Grazia Romanelli, Maria Teresa Valenti. Modulation of miR-146b Expression during Aging and the Impact of Physical Activity on Its Expression and Chondrogenic Progenitors. International Journal of Molecular Sciences 2023; 24(17): 13163 doi: 10.3390/ijms241713163
|
| 43 |
Yasmina Chouik, Fanny Lebossé, Marie-Laure Plissonnier, Jean-Christophe Lega, Pierre Pradat, Teresa Antonini, Miroslava Subic, Kerstin Hartig-Lavie, Domitille Erard, François Villeret, Céline Guichon, Audrey Payancé, Sylvie Radenne, Pierre-Emmanuel Rautou, Fabien Zoulim, Massimo Levrero. Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis. iScience 2023; 26(8): 107427 doi: 10.1016/j.isci.2023.107427
|
| 44 |
Zain Moosvi, Felix H. Lui, Douglas Nguyen. Liver Diseases. 2020; : 407 doi: 10.1007/978-3-030-24432-3_35
|
| 45 |
Catherine Jane Messner, Linda Mauch, Laura Suter-Dick. Bile salts regulate CYP7A1 expression and elicit a fibrotic response and abnormal lipid production in 3D liver microtissues. Toxicology in Vitro 2019; 60: 261 doi: 10.1016/j.tiv.2019.06.002
|
| 46 |
Sanchari Roy, Christian Trautwein, Tom Luedde, Christoph Roderburg. A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00805
|
| 47 |
A.E. Abaturov, V.L. Babуch. The role of microRNA in the development of liver diseases. Part 1. CHILD`S HEALTH 2023; 18(2): 135 doi: 10.22141/2224-0551.18.2.2023.1574
|
| 48 |
Swati Srivastava, Iti Garg, Babita Kumari, Chhavi Rai, Yamini Singh, Vinay Kumar, Uday Yanamandra, Jasjit Singh, Anju Bansal, Bhuvnesh Kumar. Diagnostic potential of circulating micro RNA hsa-miR-320 in patients of high altitude induced deep vein thrombosis: An Indian study. Gene Reports 2019; 17: 100550 doi: 10.1016/j.genrep.2019.100550
|
| 49 |
Swati Srivastava, Iti Garg, Nilanjana Ghosh, Rajeev Varshney. Therapeutic implication of MicroRNA-320a antagonist in attenuating blood clots formed during venous thrombosis. Journal of Thrombosis and Thrombolysis 2024; 57(4): 699 doi: 10.1007/s11239-024-02947-6
|